MeSH D006561 - herpes simplex
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006561:Â
Herpes simplex
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Acyclovir | Acyclovir |  | 1997-04-22 |  |  |
| Famciclovir | Famciclovir |  | 2007-08-24 |  |  | |
| Valacyclovir | Valacyclovir |  | 2010-05-24 |  |  | |
| Padagis | Acyclovir | Acyclovir |  | 2019-02-20 |  |  |
| Taro Pharmaceutical | Acyclovir | Acyclovir |  | 2016-12-21 |  |  |
| Glenmark Pharmaceuticals | Acyclovir | Acyclovir |  | 2017-07-31 |  |  |
| Mylan | Acyclovir | Acyclovir |  | 1998-04-13 |  |  |
| Valacyclovir | Valacyclovir |  | 2010-05-24 |  |  | |
| Acyclovir | Zovirax |  | 1985-01-25 |  |  | |
| NATCO Pharma | Famciclovir | Famciclovir |  | 2011-03-24 |  |  |
| Xiromed | Acyclovir | Acyclovir |  | 2020-01-29 |  |  |
| GSK | Valacyclovir | Valtrex |  | 1995-06-23 |  |  |
| Acyclovir | Zovirax |  | 1982-10-22 |  |  | |
| Cipla | Acyclovir | Acyclovir |  | 2019-01-18 |  |  |
| Famciclovir | Famciclovir |  | 2011-03-21 |  |  | |
| Valacyclovir | Valacyclovir |  | 2010-05-24 |  |  | |
| Sandoz | Valacyclovir | Valacyclovir |  | 2010-05-24 |  |  |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
50%3/6
Phase 2
75%3/4
Phase 3
85%11/13
Approved: 6Overall Success rate: 32%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use